Cytosorbents Corporation Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.13 | -$0.11 | -$0.12 |
| Q2 2024 | 1 | -$0.10 | -$0.09 | -$0.10 |
| Q3 2024 | 1 | -$0.06 | -$0.05 | -$0.06 |
| Q4 2024 | 2 | -$0.07 | -$0.06 | -$0.07 |
| Q1 2025 | 1 | -$0.07 | -$0.06 | -$0.07 |
| Q2 2025 | 1 | -$0.06 | -$0.05 | -$0.06 |
| Q3 2025 | 1 | -$0.06 | -$0.05 | -$0.06 |
| Q4 2025 | 1 | -$0.06 | -$0.05 | -$0.06 |
| Q1 2026 | 1 | -$0.03 | -$0.03 | -$0.03 |
| Q2 2026 | 1 | -$0.04 | -$0.03 | -$0.03 |
| Q3 2026 | 1 | -$0.04 | -$0.04 | -$0.04 |
| Q4 2026 | 1 | -$0.04 | -$0.04 | -$0.04 |
| Q1 2027 | 1 | $0.00 | $0.00 | $0.00 |
| Q2 2027 | 1 | $0.00 | $0.00 | $0.00 |
| Q3 2027 | 1 | $0.00 | $0.00 | $0.00 |
| Q4 2027 | 1 | $0.00 | $0.00 | $0.00 |
| Q1 2028 | 1 | $0.10 | $0.11 | $0.10 |
| Q2 2028 | 1 | $0.10 | $0.11 | $0.11 |
| Q3 2028 | 1 | $0.11 | $0.12 | $0.12 |
| Q4 2028 | 1 | $0.11 | $0.13 | $0.12 |
Cytosorbents Corporation Earnings Date And Information
Cytosorbents Corporation last posted its earnings results on Thursday, November 7th, 2024. The company reported $-0.08 earnings per share for the quarter, missing analysts' consensus estimates of $-0.07 by $0.01. The company had revenue of 8.61 B for the quarter and had revenue of 36.35 M for the year. Cytosorbents Corporation has generated $-1 earnings per share over the last year ($-0.64 diluted earnings per share) and currently has a price-to-earnings ratio of -0.02. Cytosorbents Corporation has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 6th, 2025 based on prior year's report dates.
Cytosorbents Corporation Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/07/2024 | Q3 2024 | -$0.07 | -$42.86 | -42.79 | $10.36 M | $8.61 B |
| 08/13/2024 | Q2 2024 | -$0.09 | -$0.08 | 0.01 | $9.68 M | $9.89 M |
| 05/09/2024 | Q1 2024 | -$0.12 | -$0.12 | 0 | $9.79 M | |
| 03/14/2024 | Q4 2023 | -$0.12 | $8.67 M | |||
| 11/09/2023 | Q3 2023 | -$0.12 | -$0.21 | -0.09 | $9.50 M | $7.75 M |
| 08/01/2023 | Q2 2023 | -$0.11 | -$0.14 | -0.03 | $11.03 M | $8.07 M |
| 05/02/2023 | Q1 2023 | -$0.13 | -$0.15 | -0.02 | $7.91 M | |
| 03/09/2023 | Q4 2022 | -$0.17 | -$0.02 | 0.15 | $7.64 M | |
| 11/03/2022 | Q3 2022 | -$0.16 | -$0.28 | -0.12 | $8.97 M | $6.46 M |
| 08/02/2022 | Q2 2022 | -$0.14 | -$0.25 | -0.11 | $9.58 M | $7.33 M |
| 05/03/2022 | Q1 2022 | -$0.15 | -$0.21 | -0.06 | $7.92 M | |
| 03/10/2022 | Q4 2021 | -$0.22 | $9.70 M | |||
| 11/04/2021 | Q3 2021 | -$0.12 | -$0.15 | -0.03 | $9.70 M | $8.90 M |
| 08/03/2021 | Q2 2021 | -$0.04 | -$0.11 | -0.07 | $12.27 M | $11.37 M |
| 05/04/2021 | Q1 2021 | -$0.03 | -$0.10 | -0.07 | $10.14 M | |
| 03/09/2021 | Q4 2020 | -$0.01 | -$0.02 | -0.01 | $11.53 M | |
| 11/04/2020 | Q3 2020 | -$0.09 | -$0.02 | 0.07 | $9.49 M | $10.25 M |
| 08/04/2020 | Q2 2020 | -$0.08 | -$0.08 | 0 | $9.62 M | $9.52 M |
| 05/05/2020 | Q1 2020 | -$0.14 | -$0.10 | 0.04 | $8.16 M | |
| 03/05/2020 | Q4 2019 | -$0.17 | -$0.12 | 0.05 | $6.61 M |
Cytosorbents Corporation Earnings: Frequently Asked Questions
-
When is Cytosorbents Corporation's earnings date?
Cytosorbents Corporation has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 6th, 2025 based off last year's report dates.
-
How can I listen to Cytosorbents Corporation's earnings conference call?
The conference call for Cytosorbents Corporation's latest earnings report can be listened to online.
-
How can I read Cytosorbents Corporation's conference call transcript?
The conference call transcript for Cytosorbents Corporation's latest earnings report can be read online.
-
How much revenue does Cytosorbents Corporation generate each year?
Cytosorbents Corporation (:CTSO) has a recorded annual revenue of $36.35 M.
-
How much profit does Cytosorbents Corporation generate each year?
Cytosorbents Corporation (:CTSO) has a recorded net income of $36.35 M. Cytosorbents Corporation has generated $-0.64 earnings per share over the last four quarters.
-
What is Cytosorbents Corporation's price-to-earnings ratio?
Cytosorbents Corporation (:CTSO) has a price-to-earnings ratio of -0.02 and price/earnings-to-growth ratio is 0.
